Related Experiment Video
Updated: Jul 28, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Gastric cancer treatment: recent progress and future perspectives
Wen-Long Guan1,2, Ye He1,2, Rui-Hua Xu3,4
1Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 Dongfeng Road East, Guangzhou, 510060, People's Republic of China.
Systemic treatments for gastric cancer (GC) are advancing, with chemotherapy, targeted therapy, and immunotherapy showing promise. Biomarker-driven approaches personalize treatment for better outcomes in resectable and metastatic GC.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Gastric cancer (GC) is a prevalent malignancy often diagnosed at advanced stages.
- Subtle early symptoms and low screening rates contribute to late diagnosis.
- Systemic therapies for GC have seen significant recent advancements.
Purpose of the Study:
- To review research progress in systemic treatments for gastric cancer.
- To discuss current individualized treatment strategies based on molecular biomarkers.
- To present future perspectives in gastric cancer therapy.
Main Methods:
- Systematic review of recent research on systemic therapies for gastric cancer.
- Analysis of advancements in chemotherapy, targeted therapy, and immunotherapy.
- Evaluation of biomarker-driven classification for personalized treatment.
Main Results:
- Perioperative chemotherapy is standard for resectable GC.
- Targeted therapy and immunotherapy are being investigated for perioperative/adjuvant settings.
- Immunotherapy and biomarker-directed therapies show recent advancements for metastatic GC.
- Molecular biomarkers like PD-L1, MSI, and HER2 aid in patient stratification for immunotherapy and targeted therapy.
Conclusions:
- Personalized treatment strategies are emerging for gastric cancer.
- Molecular diagnostics are crucial for characterizing GC and identifying therapeutic targets.
- Continued research into systemic treatments and targeted therapies holds promise for improved patient outcomes.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Treatment Resistant Cancers
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

